Indivior and Supernus Pharmaceuticals agreed to a tax-free merger of equals, and they are also seeking FDA approval for a second ONAPGO supplier.
3 reports, 1 independent
Updated Aug 5
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Indivior and Supernus Pharmaceuticals agreed to a tax-free merger of equals, and they are also seeking FDA approval for a second ONAPGO supplier.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Indivior
specialty pharmaceuticals business headquartered in Richmond, Virginia